Net Cash Provided by (Used in) Operating Activities |
-495 |
USD |
+92.2% |
Q4 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q4 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
58.4M |
shares |
+5.61% |
Q2 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-495 |
USD |
-1447% |
Q4 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.18K |
USD |
+643% |
Q2 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
-100% |
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
254K |
USD |
+49.4% |
Q3 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
254K |
USD |
+49.4% |
Q3 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Additional Paid in Capital |
10M |
USD |
+2.7% |
Q2 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2023 |
FY 2023 |
Interest Expense |
11.5K |
USD |
-4.49% |
Q2 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |